ABAngus Charles Burns

Angus Charles Burns

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Angus Charles Burns has a total of 196 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sleep Irregularity and Risk of Incident Hypertension in the UK Biobank

    by Kaitlin S Potts, Sina Kianersi, Tariq Faquih, Raymond Noordam, Martin K. Rutter, Tamar Sofer, Sean Cain, Daniel Windred, Angus Charles Burns, Andrew J.K. Phillips, et al.

    Background: Irregular sleep patterns are common and have been associated with higher cardiovascular disease (CVD) risk. Hypertension is the leading modifiable cause of CVD, but evidence linking irregular sleep to hypertension is inconsistent. The objective of this study was to quantify associations between irregular sleep and incident hypertension. Methods: We conducted a prospective cohort study among 55,572 UK Biobank participants without hypertension or anti-hypertensive medication use who provided 5 valid days of accelerometry in 2013-2015 (60% women, mean age 61 years). We measured sleep regularity using the intra-individual standard deviation (SD) of sleep duration and the sleep regularity index (SRI), a measure of the similarity of sleep-wake patterns from one day to the next. Cox proportional hazards models estimated adjusted hazard ratios (HR) for incident hypertension, identified through linked health records, by levels of sleep regularity adjusting for demographic, socioeconomic, and lifestyle factors as well as employment schedule. We also evaluated differences by demographic, clinical, and sleep-related (defined by duration, efficiency, timing, and sleep disorders) subgroups, and interaction with genetic susceptibility to hypertension. Results: During 7.9 years of follow-up, 5,713 participants developed hypertension. Participants with sleep duration SD >90 minutes had an 18% higher risk of incident hypertension compared to those with sleep duration SD 30 minutes (HR: 1.18; 95% confidence interval (CI): 1.06, 1.31). Similarly, participants in the lowest SRI quintile had a 40% higher risk than those in the highest SRI quintile (HR: 1.40; 95% CI: 1.29, 1.52). These associations were generally consistent across demographic, health, and sleep-defined subgroups. Sleep irregularity and genetic susceptibility contributed independently to hypertension risk, without evidence of interaction. Conclusions: Irregular sleep patterns were associated with higher incident hypertension risk independent of established risk factors and genetic susceptibility. Maintaining regular sleep schedules may represent a modifiable behavioral target for hypertension prevention.

  • Open Access

    Dual foundation models for accelerometry predict future health

    by Marcus Dige, Niels R. Lorenzen, Magnus Ruud Kjær, Angus Burns, Poul Jennum, Emmanuel H. During, James Zou, Emmanuel Mignot, Andreas Brink-Kjaer

    Wrist accelerometers are ubiquitous and capture activity, sleep, and cardiorespiratory motion, but how this relates to future disease across the phenome is unclear. We encoded one week of UK Biobank accelerometry from 97,696 participants using two frozen self-supervised models and trained a multilabel survival model on these embeddings with participant age and sex for 390 outcomes. In 5,253 held-out participants, mean concordance was 0.688. A single component explained 76% of predicted risk variance and was associated with future disease burden and mortality. Nevertheless, disease-specific scores added discrimination beyond this shared axis for 85 of 101 well-powered outcomes. A higher-powered full-cohort out-of-fold analysis identified prodromal neurodegenerative signatures, strongest for Parkinson’s disease (five-year time-dependent AUROC 0.90; 428 cases), with limited attenuation after lead-time washout. Daytime movement contributed most, whereas sleep-related and genetic information contributed selectively. These findings establish one week of wrist movement as a scalable, low-cost representation of future health for wearable-based risk assessment.

  • Open Access

    Feasibility of a contactless, self-directed, home-based dim-light melatonin onset protocol: the Circadia pilot study

    by Gregory Bormes, Jessica J Love, Angus C Burns, Oluwaseun Akeju, Jakob M Cherry, Nisha Kantesaria, Lovemore Kunorozva, Salim Qadri, Shadab A Rahman, Frank A J L Scheer, et al.

    Study Objectives: To test the feasibility of a self-directed, in-home, contactless salivary dim light melatonin onset (DLMO) assessment protocol to remotely measure endogenous circadian phase in participants with circadian rhythm disorders and healthy controls. Materials and Methods: The 4–6-week protocol involved sleep, activity, and light tracking, sleep diaries, questionnaires, and two self-directed at-home salivary sample collections for DLMO one week apart with objective compliance measures. Individuals participated remotely using an online portal and received a mailed kit. The study population included five cases with Circadian-Rhythm Sleep–Wake Disorders and five controls ages 27-63. Results: Salivary DLMO times could be calculated for 14/20 assessments, resulting in 8/10 participants with at least 1 valid DLMO and 6/10 having valid DLMOs for both. Failures in DLMOs resulted from compliance errors (eg, bright light levels) or consistently below/above threshold melatonin levels. After completing the DLMO collections, 70% of participants felt confident after completing DLMO 1, while 90% felt confident after DLMO 2. DLMO occurred on average at 24.08 hours (SEM = 1.10 hours) for four participants with Delayed Sleep Wake Phase Disorder, and at 21.37 hours (SEM = 0.71 hours) for five controls. The first and second DLMOs were strongly correlated (r = 0.98, p < .001). Conclusions: Our results indicate that contactless, self-directed, at-home DLMO assessments are feasible, reliable, and capable of detecting clinically relevant differences in circadian timing. The current protocol may serve as a framework to reliably and scalably assess circadian phase in both clinical and general populations. Statement of Significance Here, we report results of a pilot study regarding feasibility and accuracy of the first contactless, self-directed dim-light melatonin assessments, requiring no in-lab visitations. Our results indicate that contactless, self-directed, at-home dim light melatonin onset assessments are feasible, reliable and capable of detecting clinically relevant differences in circadian timing. This pilot study addresses the needs of a diverse patient population by increasing accessibility and simplifying diagnostic tools.

  • Proposal for Circadian Rhythms and Their Behavioral Outputs as Biomarkers in DSM-6 : Response to Cuthbert et al.

    by Jacob J. Crouse, Joanne S. Carpenter, Angus C. Burns, Tone E. G. Henriksen, Michael J. McCarthy, Kathleen R. Merikangas, Nicholas Meyer, Jan Scott, Mirim Shin, Daniel J. Smith, et al.


  • Open Access

    Sleep regularity outweighs sleep duration as a predictor of disease

    by Daniel P Windred, Angus C Burns, Amy Reynolds, Kelly Sansom, Bastien C Lechat, Hannah Scott, Robert Adams, Dorothee Steven, Richa Saxena, Martin Rutter, et al.

    Sleep regularity, the consistency of sleep-wake timing from one day to the next, is more strongly associated with longevity than adequate sleep duration. Whether this relationship persists across common diseases is unknown. We compared sleep regularity vs. sleep duration as risk factors for 199 diseases and disorders, using ten million hours of objective sleep-wake data (N=60,998, age[mean±SD]=62.8±7.8, 55% female). Multivariable-adjusted risks of incident diseases/disorders for regular/irregular and short/adequate sleepers were compared across 9.5 years of follow-up. Irregular sleep predicted risks for 131 diseases/disorders, more than double the number predicted by short sleep duration (63). Irregular sleep was a superior predictor than short sleep duration for 90 diseases/disorders, including circulatory, metabolic, digestive, renal, infectious, neurological, and musculoskeletal conditions, and mental disorders, whereas short sleep duration was the superior predictor for only 9 diseases/disorders. For models where short sleep duration explained disease risks, 83% were improved by adding sleep regularity. Sleep regularity was a stronger predictor of diseases/disorders than sleep duration in this cohort and should be considered an essential dimension of sleep health.


  • Open Access

    24-hour sleep-wake regularity and cognitive aging among 74,733 middle-aged and older adults from the US and Europe: The LifeSPAN Consortium

    by Sanne J.W. Hoepel, Alice Albrecht, Jiawen Chen, Lachlan Cribb, Ian M. Danilevicz, Aron S Buchman, Lisa L. Barnes, David A Bennett, Suzanne M Bertisch, Angus C Burns, et al.

    Importance: Irregular sleep-wake patterns have been associated with poor health and cognitive outcomes, yet evidence linking 24-hour sleep-wake regularity to cognitive decline or dementia remains inconsistent. Particularly, regularity can be measured as regularity of rest-wake, sleep-wake or overall 24-hour activity, but it is unclear which aspects are most relevant for cognitive aging. Objective: To assess associations of rest-wake, sleep-wake, and 24-hour activity regularity with cognitive decline and dementia risk. Design: Observational prospective study comprised of six US and European cohorts: MrOS (sleep study between 2003-2005, mean follow-up: 7.1 years), Rotterdam Study (2004-2007, 11.6 years), MESA (2010-2013, 8.2 years), MAP (2005-2018, 7.2 years), Whitehall II (2012-2013, 6.9 years), and UKB (2013-2015, 7.9 years). Setting: Cohort-specific estimates were pooled using random-effects meta-analysis. Analyses were done between June 2025 and March 2026. Participants 74,733 dementia-free adults with multi-day actigraphy were included across cohorts: MrOS (age: 67-96 years, female:0%), MESA (54-95y, female:54.6%), Rotterdam Study (46-98y, female:55.0%), MAP (56-100y, female:77.1%), Whitehall II (59-83y, female:25.9%), and UKB (55-78y, female:55.5%). Exposure: Day-to-day rest-wake regularity (Rest Regularity Index, RRI), day-to-day sleep-wake regularity (Sleep Regularity Index, SRI), and 24-hour activity regularity (Interdaily Stability, IS) were derived from multi-day actigraphy. Main Outcome: Outcomes were risk of dementia and changes in global cognition. Results: Across six cohorts, 1,906 dementia cases occurred among 74,733 participants. After adjusting for demographics, health behaviors, depressive symptoms and cardiovascular comorbidities, each 1-SD higher regularity score was associated with an 9-14% lower dementia risk (pooled hazard ratios: RRI 0.86 95%CI: [0.79-0.95]; SRI 0.87[0.79-0.97]; IS: 0.91[0.88-0.95]). Associations were approximately linear. Age-stratified analyses showed directionally stronger associations among adults aged < 65, although meta-regression did not support an interaction(p > 0.55). Greater regularity was associated with modestly slower decline in global cognition (pooled β per 1-SD higher score of RRI per year: 0.003, 95%CI [0.001-0.006]). Conclusions & Relevance: Greater regularity of rest-wake, sleep-wake, and 24-hour activity rhythms was associated with lower dementia risk and modestly slower global cognitive decline. These findings suggest that 24-hour sleep-wake regularity is a relevant behavioral marker of cognitive aging and may inform future efforts to identify or intervene on early risk.

  • Open Access

    Circadian rhythms regulate refractive development across species

    by Teele Palumaa, Nele Taba, Shruti Balamurugan, Angus C. Burns, Jakob M. Cherry, Shane P. D'Souza, Maris Teder-Laving, Richa Saxena, Tonu Esko, Erik Abner, et al.

    Myopia is a rapidly escalating global public health challenge, yet the biological mechanisms linking modern lifestyles to abnormal eye growth remain unclear. Circadian rhythms have been implicated in refractive development, but causal evidence is limited. Here, we integrate population-scale human data with an experimental animal model to determine whether circadian misalignment contributes to myopia. In >265,000 individuals from the Estonian and UK Biobanks, late chronotype was consistently associated with myopia. To assess causality, we experimentally disrupted the alignment between behavioural and environmental rhythms in mice by housing them in non-24-hour light-dark schedules. Exposure to a lengthened cycle (T26) induced a myopic shift that was, notably, reversible in early adulthood. Retinal transcriptomics revealed enrichment of mitochondrial and hypoxia-related plasticity pathways, with transcriptional changes distributed across multiple retinal cell classes. Together, these findings identify circadian misalignment as a conserved and modifiable driver of myopia, highlighting opportunities for novel preventive and therapeutic approaches.


  • Open Access

    Local clocks within human tissues reveal widespread 24-hour rhythms in gene expression

    by Teele Palumaa, Jakob M. Cherry, Priit Palta, Angus C. Burns

    Circadian clocks govern the 24-hour rhythmic activity of organs across the human body and these nycthemeral rhythms are critical for human physical and mental health. Here, we analysed 14,886 samples across 45 human tissues and inferred tissue-specific local phases using CHIRAL to define the rhythmic transcriptome. Local phase inference identified a median of 5,747 rhythmic transcripts across tissues, including 5,531 across brain tissues, indicating that prior donor-level approaches have substantially underestimated the extent of rhythmic transcription in the human brain. In the brain, rhythmic genes were enriched for neurotransmitter pathways, the synaptic vesicle cycle, circadian entrainment and major neurodegenerative disorders. Strikingly, more than 200 genes in Alzheimer’s, Parkinson’s, Huntington’s and prion disease pathways displayed significant 24-hour rhythmicity across cortical, striatal and hippocampal regions, segregating into distinct diurnal and nocturnal phase clusters. These included Parkinson’s disease genes SNCA and PRKN , Alzheimer’s disease genes PSEN1 and APP , prion disease genes PRNP and EIF2AK3 ( PERK ), and Huntington’s disease genes HTT and GPR52 . Among these disease-associated rhythmic transcripts were several targets already under therapeutic investigation for which administration at specific times of day may improve therapeutic efficacy or tolerability. Here, we observe that human tissues, including the brain, exhibit distinct local rhythmic organisation. These findings provide novel insights into disease mechanisms and highlight opportunities for target discovery, drug development and chronotherapeutic intervention.

  • Open Access

    Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants

    by Frank Geller, Xiaoping Wu, Vilma Lammi, Erik Abner, Jesse Tyler Valliere, Katerina Nastou, Angus Burns, Morten Rasmussen, Niklas Worm Andersson, Liam Quinn, et al.

    The host genetics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have previously been studied based on cases from the earlier waves of the pandemic in 2020 and 2021, identifying 51 genomic loci associated with infection and/or severity. SARS-CoV-2 has shown rapid sequence evolution, increasing transmissibility, particularly for Omicron variants, which raises the question of whether this affected the host genetic factors. We performed a genome-wide association study of SARS-CoV-2 infection with Omicron variants, including more than 150,000 cases from four cohorts. We identified 13 genome-wide significant loci, of which only five were previously described as associated with SARS-CoV-2 infection. The strongest signal was a single nucleotide polymorphism in an intron of ST6GAL1, a gene affecting immune development and function, connected to three other associated loci (harboring MUC1, MUC5AC and MUC16) through O-glycan biosynthesis. Our study provides robust evidence for individual genetic variation related to glycosylation, translating into susceptibility to SARS-CoV-2 infections with Omicron variants.


  • Open Access

    Genome wide association study of a Circadian Imbalance Index in 312,935 European ancestry UK Biobank participants identifies loci related to diabetes, mood and myocardial infarction

    by Magdalena Żebrowska, Matthias Wielscher, Jing Zhang, Ingvild Saksvik-Lehouillier, Lee DiMilia, Angus Burns, Jesse Valliere, Leonardo Vincenzi, Susan Redline, Olivia I Okereke, et al.

    The Circadian Imbalance Index (CII) integrates chronotype, sleep duration, neuroticism, caffeine intake, and vitamin D. In a genome wide association study (GWAS) of CII in 312,935 European ancestry UK Biobank participants, we identified 27 loci mapping to 72 genes, including circadian regulators CALCA, DHCR7, KDM5A, HAL, and CRX. Gene-overlap analyses demonstrated shared architecture with CII components, while EPHB1, SERPING1, C12orf74, PLEKHG7, and EEA1 were uniquely associated with CII. A CII polygenic score (CII-PRS) showed phenome-wide associations with type 2 diabetes (T2D), major depressive disorder, and obesity. Genetic correlations linked CII with insomnia, mood symptoms, body mass index (BMI), T2D, coronary artery disease (CAD), and myocardial infarction (MI). Mendelian randomization suggested causal effects of CII on T2D, mood swings, and MI, and reverse effects of CAD, mood, and MI on CII. This work shows that circadian imbalance is a polygenic trait connecting sleep-related biology to metabolic, cardiovascular and mood health outcomes.